Abstract:T cells accumulate in adipose tissue (AT) and change phenotypes, with increased polarization to Th1, in obesity, but the mechanisms for these changes and their contribution to metabolic functions remain incompletely understood. We hypothesize that STAT1, a transcription factor, plays a role in AT T cell polarization, thus impacting obesity and related metabolism. Mice with Stat1 knockout in αβT cells (tStat1-KO) were generated by crossbreeding Stat1fl/fl mice and CD4-cre mice. Strikingly, with high-fat diet (HFD) feeding or aging, tStat1-KO, compared to cre noncarrier wild type (WT) littermates, developed less obesity, with lower body weight and fat mass (body weight: 43 ± 0.5 g in KO [n=33] vs 48 ± 0.8 g in WT [n=32] at 12 weeks on HFD and 32 ± 0.7 g in KO [n=27] vs 37 ± 0.6 g in WT [n=25] at the age of 50 weeks [on normal chow], P<0.001; fat mass: 14 ± 0.5 g in KO [n=6] vs 17 ± 0.7 g in WT [n=4] at 12 weeks on HFD, P=0.02 and 4.6 ± 0.3 g in KO [n=9] vs 8.6 ± 1.5 g in WT [n=4] at the age of 50 weeks, P=0.002). Compared to WT, tStat1-KO had similar food intake, but increased energy expenditure with increased white AT browning indicated by elevated UCP1 and PRDM16 levels in inguinal AT. tStat1-KO vs WT with HFD or aging had improved insulin sensitivity and glucose tolerance. Analyses of AT showed a dramatic phenotypic switch from IFNγ+ Th1 to IL-5+ Th2 cells and increased eosinophils in perigonadal and inguinal AT of tStat1-KO vs WT fed HFD. Antibody neutralization of IL-5 reduced eosinophils but did not reverse less obesity in tStat1-KO fed HFD, suggesting that increased IL-5 and eosinophils may not account for reduced obesity in tStat1-KO. Adoptive transfer of Th1 cells in tStat1-KO and tissue culture studies showed that Th1 cells repressed white AT browning and reduced UCP1 in adipocytes. In summary, T cell ablation of STAT1 led to phenotypic switch from Th1 to Th2 cells in AT, correlated with reduced obesity, in mice with HFD or aging. These data support a role of STAT1 in AT T cell polarization, which may affect obesity development induced by HFD or aging. Disclosure Z.Lian: None. V.O'brien: None. X.D.Perrard: None. P.Saha: None. S.M.Hartig: None. C.M.Ballantyne: Consultant; Alnylam Pharmaceuticals, Inc., Althera Pharmaceuticals, Amarin Corporation, Amgen Inc., Arrowhead Pharmaceuticals, Inc., AstraZeneca, ESPERION Therapeutics, Inc., 89bio, Inc., Abbott Diagnostics, Denka Seiken, Genentech, Inc., Gilead Sciences, Inc., Illumina, Matinas BioPharma Inc, Merck & Co., Inc., New Amsterdam Pharma, Novartis, Novo Nordisk, Pfizer Inc., Regeneron, Roche Diagnostics, Research Support; Abbott Diagnostics, Akcea, Amgen Inc., Arrowhead Pharmaceuticals, Inc., ESPERION Therapeutics, Inc., Ionis Pharmaceuticals, Merck & Co., Inc., Novartis, Novo Nordisk, Regeneron, Roche Diagnostics. H.Wu: None. Funding American Diabetes Association (1-17-IBS-082 to H.W.); National Institutes of Health (R01DK121348, R01AG065197); American Heart Association (968367)

Npy transcription is regulated by noncanonical STAT3 signaling in hypothalamic neurons: Implication with lipotoxicity and obesity

Sympathetic neuropeptide Y protects from obesity by sustaining thermogenic fat

Enhancement of Hypothalamic STAT3 Acetylation by Nuclear Receptor Nur77 Dictates Leptin Sensitivity.

The Effect of Neuropeptide Y on Brown-Like Adipocyte's Differentiation and Activation

Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome

Sympathetic neuron-derived NPY protects from obesity by sustaining the mural progenitors of thermogenic adipocytes.

NLRP3 Inflammasome: Potential Role in Obesity Related Low-Grade Inflammation and Insulin Resistance in Skeletal Muscle

Neuropeptide Y Genotype, Central Obesity, and Abdominal Fat Distribution: the POUNDS LOST Trial.

Knockdown of Neuropeptide Y in the Dorsomedial Hypothalamus Promotes Hepatic Insulin Sensitivity in Male Rats

1671-P: T Cell Deficiency of STAT1 Reduces Obesity in Mice with High-Fat Diet or Aging

Neuropeptide Y promotes adipogenic differentiation in primary cultured human adipose-derived stem cells

Phosphoinositide 3-Kinase is Integral for the Acute Activity of Leptin and Insulin in Male Arcuate NPY/AgRP Neurons.

High fat induces acute and chronic inflammation in the hypothalamus: effect of high-fat diet, palmitate and TNF-α on appetite-regulating NPY neurons

Hypothalamic NPFFR2 attenuates central insulin signaling and its knockout diminishes metabolic dysfunction in mouse models of diabetes mellitus

Activation of the GP130-STAT3 axis and its potential implications in nonalcoholic fatty liver disease

239-LB: Single-Cell Analysis Identified Inhibitory Neurons Associated with High-Fat Diet in the Bed Nucleus of the Stria Terminalis

Adipocyte-derived kynurenine promotes obesity and insulin resistance by activating the AhR/STAT3/IL-6 signaling

Transcriptional regulation of neurodevelopmental and metabolic pathways by NPAS3

Agrp-negative arcuate NPY neurons drive feeding under positive energy balance via altering leptin responsiveness in POMC neurons

Molecular Profiling of Human Induced Pluripotent Stem Cell-Derived Hypothalamic Neurones Provides Developmental Insights into Genetic Loci for Body Weight Regulation

STAT1 dissociates adipose tissue inflammation from insulin sensitivity in obesity